Pancreatic Cancer

Pancreatic cancer currently has no cure, and has the highest mortality rate of any type of cancer.  The fact is pancreatic cancer is rarely detected in its first stage, when the cancer is only contained within the pancreas.  This is the only time an operation can occur with any decent chance of survival.  Currently, there is a lot of pancreatic cancer research going on to change the odds into the patient's favor.

Perhaps the biggest resource of all is the Lustgarten Foundation for Pancreatic Cancer Research.  This is a foundation solely focused on advancing the scientific and medical research of pancreatic cancer.  Research is related to the diagnosis, treatment, care and prevention of pancreatic cancer.

This foundation helps to raise more funding and support as it relates to clinical strategies to help treat pancreatic cancer.  In addition, it works at creating facilities which help communications between members of the medical scientific communities, about the latest research for pancreatic cancer.

Also, the Lustgarten Foundation for Pancreatic Cancer Research is currently working with the National Cancer institute to increase their annual budget for research related to pancreatic cancer.

And finally, it has an aim to increase the public's awareness of pancreatic cancer.

This foundation offer resources for the pancreatic cancer patient.  Such resources include not only information about the latest pancreatic cancer research, but also how to handle the challenges that come with a diagnosis of pancreatic cancer.

The resources help the patient, as wells the patient's family and caregivers, to better understand and cope with pancreatic cancer.

Not only that, it provides a service to help put interested pancreatic cancer patients in touch with over 100 clinical trials dealing with pancreatic cancer.  These trials are used by the scientific community to develop and find new ways of treating pancreatic cancer.

Currently, there are many trials that are working with different pancreatic cancer drugs.  One such trial was conducted in Germany with the results tallied at the end of 2006.  The finding was that a certain drug, administered during chemotherapy, helped increase the patient's lifespan by seven months.  Unfortunately, the survival rate was still the same.

In conclusion, I have given you some information about what is going on in the world of pancreatic cancer research.  Use these resources to stay up to date with the latest news and developments relating to pancreatic cancer.

Pancreatic Cancer |